Clinical Cancer Drugs

ISSN (Print): 2212-697X
ISSN (Online): 2212-6988

Volume 8 , Issues 2, 2021

This journal supports open access

Back Journal Home
Topic(s) Covered

1 Topic(s)

View
Covered Disease(s)

1 Disease(s)

View

Aims & Scope

Clinical Cancer Drugs publishes original research and (as well as) expert reviews, and thematic issues in all core areas of translational and clinical cancer drug research.

The journal publishes pre-clinical and clinical studies on the development of new anti-cancer agents. Clinical studies of new reported anti-cancer drugs include Phase 1–IV clinical trial studies, their designs, research methodologies, and analyses. The journal is essential reading to clinical oncologists, toxicologists, medicinal chemists, and to pharmacologists.

Abstracted/Indexed in


Chemical Abstracts Service/SciFinder, CNKI Scholar, Dimensions, EBSCO, EMBASE, Google Scholar, J-Gate, JournalTOCs, PubsHub, QOAM, Scilit, Suweco CZ, and Ulrich's Periodicals Directory.

Special Offers

Quick processing and publication of the submitted papers. The manuscript will be published online within 20 days of final acceptance.

30% discount on the single-issue cost to authors on the purchase of issue(s) in which their article is published.
Multiple issue copies at discounted rates.

Announcements
© 2022 Bentham Science Publishers | Privacy Policy